Does the National Health Insurance Card Allow us to Predict Antibiotic Resistance?

The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421

NCT02847065 ·Status: COMPLETED

Prevalence of Digestive Carriage of Integrons

NCT01985217 ·Status: COMPLETED

Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria

NCT01771432 ·Status: UNKNOWN ·Phase: NA

Dynamics of the Urinary Bacterial Microbiota

NCT07020676 ·Status: COMPLETED

Clinical Evaluation of Beta-Lacta ™ Test in Urinary Infections

NCT02897609 ·Status: COMPLETED

Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood

NCT02482051 ·Status: COMPLETED

Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals

NCT02007343 ·Status: COMPLETED

Multi-Antibiotic Resistance Carriage in Gut Flora

NCT01591538 ·Status: COMPLETED

Evaluation of Antibiotherapy Prescribed for Outpatients From Emergency Departments

NCT05350995 ·Status: UNKNOWN

Prevalence of Clinical Strains of Enterobacteria With Reduced Susceptibility to Carbapenems in the North-West Region of France

NCT02799225 ·Status: COMPLETED

Urinary Tract Infections Caused by ESBL-producing Enterobacteria

NCT03501901 ·Status: COMPLETED

Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria

NCT06910878 ·Status: RECRUITING

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis

NCT01345929 ·Status: COMPLETED ·Phase: PHASE3

A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.

NCT07234331 ·Status: RECRUITING

Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI)

NCT07012421 ·Status: RECRUITING

Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases

NCT02127450 ·Status: COMPLETED

Antibiotic Resistant Community-Acquired E. Coli

NCT00298103 ·Status: COMPLETED

Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae

NCT02005159 ·Status: COMPLETED

Spectrum of Bacterial Infections in Rheumatology

NCT05007405 ·Status: COMPLETED

Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region

NCT02803710 ·Status: UNKNOWN

Are the Patients Having Pets at Greater Risk of Carrying Multidrug Resistance Bacteriae?

NCT03352804 ·Status: COMPLETED

Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis

NCT03179384 ·Status: COMPLETED ·Phase: PHASE4

Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital

NCT05798351 ·Status: RECRUITING

Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares

NCT00976638 ·Status: COMPLETED ·Phase: NA

Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae

NCT01138566 ·Status: UNKNOWN